210 related articles for article (PubMed ID: 37491929)
1. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
[TBL] [Abstract][Full Text] [Related]
2. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
Sapir T; Carp H; Shoenfeld Y
Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.
Kim JH; Kim SH; Yang N; Ko Y; Lee SR; Chae HD
J Korean Med Sci; 2022 Jun; 37(25):e200. PubMed ID: 35762143
[TBL] [Abstract][Full Text] [Related]
4. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?
Egerup P; Kolte AM; Larsen EC; Krog M; Nielsen HS; Christiansen OB
Hum Reprod; 2016 Nov; 31(11):2428-2434. PubMed ID: 27591241
[TBL] [Abstract][Full Text] [Related]
5. Reproductive outcomes of women with recurrent pregnancy losses and repeated implantation failures are significantly improved with immunomodulatory treatment.
Sung N; Khan SA; Yiu ME; Jubiz G; Salazar MD; Skariah A; Dambaeva S; Kwak-Kim J
J Reprod Immunol; 2021 Nov; 148():103369. PubMed ID: 34492567
[TBL] [Abstract][Full Text] [Related]
6. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
Yang X; Meng T
J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
[TBL] [Abstract][Full Text] [Related]
7. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.
Peero EK; Banjar S; Khoudja R; Ton-Leclerc S; Beauchamp C; Benoit J; Beltempo M; Dahan MH; Gold P; Kadoch IJ; Jamal W; Laskin C; Mahutte N; Phillips S; Sylvestre C; Reinblatt S; Mazer BD; Buckett W; Genest G
Sci Rep; 2024 Feb; 14(1):3876. PubMed ID: 38365988
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial.
Nørgaard-Pedersen C; Nielsen K; Steffensen R; Eriksen L; Jørgensen MM; Kesmodel US; Christiansen OB
BMJ Open; 2022 Sep; 12(9):e064780. PubMed ID: 36137638
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.
Stephenson MD; Kutteh WH; Purkiss S; Librach C; Schultz P; Houlihan E; Liao C
Hum Reprod; 2010 Sep; 25(9):2203-9. PubMed ID: 20634190
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
EClinicalMedicine; 2022 Aug; 50():101527. PubMed ID: 35795714
[TBL] [Abstract][Full Text] [Related]
13. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone and live birth in unexplained recurrent pregnancy loss.
Bliddal S; Feldt-Rasmussen U; Forman JL; Hilsted LM; Larsen EC; Christiansen OB; Nielsen CH; Kolte AM; Nielsen HS
Reprod Biomed Online; 2023 Jun; 46(6):995-1003. PubMed ID: 37055255
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, causes, and impact of non-visualized pregnancy losses in a recurrent pregnancy loss population.
Bedaiwy MA; Fayek B; Yang EC; Iews MS; Elgendi M; Abdelkareem AO; Abdellah AH; Liu YD; Jones A; Mayer U; Abdel Hafez FF
Hum Reprod; 2023 May; 38(5):830-839. PubMed ID: 36881694
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the role of paternal factors in aetiology and prognosis of recurrent pregnancy loss: study protocol for a hospital-based multicentre case-control study and cohort study (REMI III project).
du Fossé N; van der Hoorn ML; Eikmans M; Heidt S; le Cessie S; Mulders A; van Lith J; Lashley E
BMJ Open; 2019 Nov; 9(11):e033095. PubMed ID: 31727666
[TBL] [Abstract][Full Text] [Related]
18. The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss.
Cheloufi M; Kazhalawi A; Pinton A; Rahmati M; Chevrier L; Prat-Ellenberg L; Michel AS; Dray G; Mekinian A; Kayem G; Lédée N
Front Immunol; 2021; 12():656701. PubMed ID: 33841443
[TBL] [Abstract][Full Text] [Related]
19. External validation of a frequently used prediction model for ongoing pregnancy in couples with unexplained recurrent pregnancy loss.
Youssef A; van der Hoorn MLP; Dongen M; Visser J; Bloemenkamp K; van Lith J; van Geloven N; Lashley EELO
Hum Reprod; 2022 Mar; 37(3):393-399. PubMed ID: 34875054
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study.
Bhatt SJ; Marchetto NM; Roy J; Morelli SS; McGovern PG
Hum Reprod; 2021 Jul; 36(8):2339-2344. PubMed ID: 34027546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
